ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, w...
3 Marras 34min
ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, w...
3 Marras 34min
A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran
Could sirolimus-coated balloons change how we treat femoropopliteal peripheral artery disease? Host Mitsuaki Sawano, MD, welcomes Yoshimitsu Soga, MD, PhD (Kokura Memorial Hospital) to discuss the 3-y...
20 Loka 28min
Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran
Which of the thousands of biomarkers associated with cardiovascular disease could actually become a useful drug target? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura, MD, welcome Satoshi Yosh...
13 Loka 35min
PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran
Hosts Mitsuaki Sawano, MD, Satoshi Shoji, MD, and Kentaro Ejiri, MD, welcome Yoshito Kadoya, MD, PhD (University of British Columbia / St. Paul’s Hospital) to discuss his JACC: Cardiovascular Imaging ...
6 Loka 36min
Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran
Host Mitsuaki Sawano, MD, welcomes Shuhei Nomura, PhD (Tohoku University), Lisa Yamasaki, MD (Harvard T.H. Chan School of Public Health), and Haruka Sakamoto, MD, PhD (St. Luke’s International Hospita...
29 Syys 39min
PFA Changes the Game and the AT Circuit | JACC Baran
Hosts Mitsuaki Sawano, MD, and Hiroyuki Sato, MD, welcome Kazutaka Nakasone, MD (Kobe University) to discuss his JACC: Clinical Electrophysiology study on atrial tachycardia (AT) after pulsed field ab...
22 Syys 36min
